HomeLBank Stocks
Outset Medical Inc
Outset Medical Inc

Outset Medical Inc (OM)

24HHigh$4.0924HLow$3.54
$3.95
+0.05%

Last updated: 2026-10-03 11:07:05

K-Line Chart, actual market data is subject to the trading page.

Key Data

Prev. Open
$3.77
Prev. Close
$3.95
Prev. Day's Range
$3.54 - $4.09
52W Range
$2.84 - $16.16
Trading Volume
458.553K
MC
$70.489M
P/E Ratio
--
EPS
$-3.80

Company Overview

NASDAQ

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. The company is headquartered in San Jose, California.

SectorHEALTHCARE
IndustryMEDICAL DEVICES
Headquarters3052 ORCHARD DRIVE, SAN JOSE, CA, UNITED STATES, 95134
CountryUSA
Listing Date2020-09-15
Fiscal Year Ended2026-06-30
Shares Outstanding18.797M
CIK Code1484612

Financial Metrics

Indicator2026-06-302026-03-312025-12-312025-09-30
Income$31.635M$27.863M$28.874M$29.431M
Operating Expenses$18.353M$15.768M$16.643M$17.841M
Net Income-$17.984M-$18.978M-$19.491M-$17.838M
Net Profit Margin-56.8%-68.1%-67.5%-60.6%
Earnings Per Share--$-1.03$-1.09$-1.00
EBITDA-$12.9M-$14.597M-$15.074M-$13.636M
Effective Tax Rate-1.2%-1.2%-0.5%-2.3%

FAQ

OM focuses on providing specialized software and technology solutions for the industrial and manufacturing sectors. Its core business involves delivering tools and platforms that streamline operations, improve productivity, and optimize industrial workflows. The company serves a wide range of clients, helping them integrate advanced technologies into their processes to achieve greater efficiency.
OM operates in the industrial technology sector, specifically within the technology-driven manufacturing solutions industry. The company designs and offers cutting-edge tools, software, and systems aimed at enhancing operational efficiency and enabling digital transformation in industrial processes.
OM’s main competitors include other industrial technology companies that provide software and systems for manufacturing and operational optimization. These include firms like Rockwell Automation, Emerson Electric, and Honeywell, which also focus on similar markets and technologies.
The primary revenue drivers for OM include its range of industrial software solutions, licensing agreements, and recurring service contracts. Additionally, the company benefits from business expansions in the technology space, driven by increased demand for automation and digital transformation in manufacturing.
Key opportunities for OM include increased adoption of automation, Industry 4.0 technologies, and the digitalization of manufacturing processes worldwide. However, risks include economic downturns affecting industrial investments, competition from established players, and challenges around technological innovation to meet evolving client needs.
OM does not currently pay dividends, as it focuses on reinvesting profits to expand its business operations and enhance its technological offerings. Investors should consider this reinvestment strategy when evaluating the company's potential for growth and long-term value creation.
OM’s valuation is typically assessed by looking at metrics such as price-to-earnings (P/E) and price-to-sales (P/S) compared to its industrial technology peers. While specific ratios depend on market conditions, valuation may reflect its growth potential, technological innovation, and market share within the sector.
Investors should weigh OM’s potential for growth through innovation, its position in the industrial technology market, and the increasing demand for manufacturing automation. They should also assess competition, economic cycles affecting industrial clients, and any risks tied to the adoption of its solutions.
Risk Warning
  1. 1.Stock prices may fluctuate significantly; invest with caution. Past performance is not indicative of future results.
  2. 2.Digital asset trading involves multiple risks, including market and technical risks. Please make rational decisions and allocate assets wisely.
  3. 3.The information contained on this page is for reference only and does not constitute any investment advice.